Standardized Supportive Care Documentation Improves Safety of High‐Dose Methotrexate Treatment

BACKGROUND: High‐dose (HD) methotrexate (MTX) is an essential component of treatment protocols in acute lymphoblastic leukemia, aggressive lymphoma, and osteosarcoma. However, delayed MTX clearance may lead to life‐threatening toxicities. Administration of supportive therapy for HD‐MTX is complex, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsdorf, Winfried H., Karagiannis, Panagiotis, Langebrake, Claudia, Bokemeyer, Carsten, Frenzel, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873314/
https://www.ncbi.nlm.nih.gov/pubmed/33215763
http://dx.doi.org/10.1002/onco.13603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873314/
https://www.ncbi.nlm.nih.gov/pubmed/33215763
http://dx.doi.org/10.1002/onco.13603

Ejemplares similares